Literature DB >> 9016587

Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.

K Verhoef1, M Tijms, B Berkhout.   

Abstract

HIV-1 transcription from the LTR promoter is activated by the viral Tat protein through interaction with the nascent TAR RNA hairpin structure. The mechanism of Tat-mediated transcriptional activation has been extensively investigated with LTR-CAT reporter genes in transient transfections and, more recently, in infection experiments with mutant HIV-1 variants. Several discrepancies between these two assay systems have been reported. For instance, whereas opening of the lower part of the TAR RNA stem does not affect the promoter activity of an LTR-CAT plasmid in transient assays, the corresponding virus mutant is fully replication-impaired. With the aim to resolve this controversy, we have examined the activity of a set of TAR RNA mutants in transient transfection experiments with a variety of cell types. We now demonstrate that truncated TAR motifs exhibit a severe, but cell-type dependent transcription defect. Whereas full LTR activity is measured in COS cells that have been used regularly in previous transfection assays, a severe defect is apparent in a variety of human cell lines, including T cell lines that are typically used in HIV-1 replication studies. These results suggest the presence of a human protein that participates in Tat-mediated transcriptional activation through binding to the lower part of the TAR stem. Several candidate co-factors have been reported in literature. This study resolves the discrepancy between transfection and infection studies on the requirements of the lower TAR stem structure. The evidence also implies that LTR transcription studies should be performed preferentially in human cell types.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016587      PMCID: PMC146473          DOI: 10.1093/nar/25.3.496

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  61 in total

1.  Revertants and pseudo-revertants of human immunodeficiency virus type 1 viruses mutated in the long terminal repeat promoter region.

Authors:  B Berkhout; B Klaver
Journal:  J Gen Virol       Date:  1995-04       Impact factor: 3.891

2.  A conserved hairpin structure predicted for the poly(A) signal of human and simian immunodeficiency viruses.

Authors:  B Berkhout; B Klaver; A T Das
Journal:  Virology       Date:  1995-02-20       Impact factor: 3.616

3.  Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.

Authors:  F Wu-Baer; D Sigman; R B Gaynor
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

4.  Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.

Authors:  M P Rounseville; H C Lin; E Agbottah; R R Shukla; A B Rabson; A Kumar
Journal:  Virology       Date:  1996-02-15       Impact factor: 3.616

5.  A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro.

Authors:  C A Parada; J B Yoon; R G Roeder
Journal:  J Biol Chem       Date:  1995-02-03       Impact factor: 5.157

6.  Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).

Authors:  A T Das; B Klaver; B Berkhout
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Molecular cloning and characterization of a TAR-binding nuclear factor from T cells.

Authors:  T R Reddy; M Suhasini; J Rappaport; D J Looney; G Kraus; F Wong-Staal
Journal:  AIDS Res Hum Retroviruses       Date:  1995-06       Impact factor: 2.205

8.  Tat-independent replication of human immunodeficiency viruses.

Authors:  L Luznik; G Kraus; J Guatelli; D Richman; F Wong-Staal
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

9.  Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication.

Authors:  D Harrich; G Mavankal; A Mette-Snider; R B Gaynor
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Interaction of nuclear protein p140 with human immunodeficiency virus type 1 TAR RNA in mitogen-activated primary human T lymphocytes.

Authors:  C J Rothblum; J Jackman; J Mikovits; R R Shukla; A Kumar
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more
  8 in total

1.  The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle.

Authors:  A T Das; B Klaver; B Berkhout
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

2.  Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells.

Authors:  R Yamamoto; S Koseki; J Ohkawa; K Murakami; S Nishikawa; K Taira; P K Kumar
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

3.  CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.

Authors:  M E Garber; T P Mayall; E M Suess; J Meisenhelder; N E Thompson; K A Jones
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.

Authors:  S F Ding; J Noronha; S Joshi
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

5.  Human immunodeficiency virus type 1 protease regulation of tat activity is essential for efficient reverse transcription and replication.

Authors:  Ann Apolloni; C William Hooker; Johnson Mak; David Harrich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Ribosomal scanning on the 5'-untranslated region of the human immunodeficiency virus RNA genome.

Authors:  Ben Berkhout; Kelly Arts; Truus E M Abbink
Journal:  Nucleic Acids Res       Date:  2011-03-09       Impact factor: 16.971

Review 7.  Extracellular vesicles and chronic inflammation during HIV infection.

Authors:  Paula Soledad Pérez; María Albertina Romaniuk; Gabriel A Duette; Zezhou Zhao; Yiyao Huang; Lorena Martin-Jaular; Kenneth W Witwer; Clotilde Théry; Matías Ostrowski
Journal:  J Extracell Vesicles       Date:  2019-11-06

8.  Creating a ribonuclease T-tat that preferentially recognizes and hydrolyzes HIV-1 TAR RNA in vitro and in vivo.

Authors:  Chen Dow-Tien; Tsai Yuan-Jhih; Lin Alan
Journal:  Nucleic Acids Res       Date:  2007-12-17       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.